🇺🇸 FDA
Patent

US 12311030

Antibody-sting agonist conjugates and their use in immunotherapy

granted A61KA61K47/6807A61K47/6849

Quick answer

US patent 12311030 (Antibody-sting agonist conjugates and their use in immunotherapy) held by The Board of Regents of the University of Texas System expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue May 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K47/6807, A61K47/6849, A61K47/6851, A61P